Smith & Nephew plc (LON:SN)
London · Delayed Price · Currency is GBP · Price in GBX 1,220.50
+0.50 (0.04%)
Dec 24, 2025, 12:35 PM BST
Smith & Nephew Market Cap
Smith & Nephew has a market cap or net worth of 10.37 billion as of December 24, 2025. Its market cap has increased by 19.69% in one year.
Market Cap
10.37B
Enterprise Value
12.40B
Revenue
4.33B
Ranking
n/a
PE Ratio
29.99
Stock Price
1,220.50
Market Cap Chart
Since December 31, 1985, Smith & Nephew's market cap has increased from 819.93M to 10.37B, an increase of 1,164.85%. That is a compound annual growth rate of 6.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 10.37B | 19.96% |
| Dec 31, 2024 | 8.65B | -7.88% |
| Dec 29, 2023 | 9.39B | -2.72% |
| Dec 30, 2022 | 9.65B | -15.11% |
| Dec 31, 2021 | 11.36B | -14.01% |
| Dec 31, 2020 | 13.22B | -17.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.01B |
| GSK plc | 72.81B |
| Haleon | 33.14B |
| Convatec Group | 4.65B |
| Hikma Pharmaceuticals | 3.38B |
| Genus | 1.72B |
| HUTCHMED (China) | 1.66B |
| Oxford Nanopore Technologies | 1.25B |